Pharmaceutical

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025

CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated…

3 months ago

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

3 months ago

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function.1Approval is…

3 months ago

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

3 months ago

Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer

VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse…

3 months ago

Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer

MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief…

3 months ago

EX DEA Administrator Anne Milgram’s “Swampy” Legacy: No-Bid Contracts, No Marijuana Reform, and No Accountability

MMJ BioPharma CEO Duane Boise summed it up bluntly:"Milgram's DEA was a monument to incompetence and indifference - and patients…

3 months ago

BioNxt Completes “Fast-Track” US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis

VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

3 months ago

Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET…

3 months ago

eschbach Awarded Two Honors in the 2025 Pharmaceutical Technology Excellence Awards for Innovations in Pharmaceutical Manufacturing

BOSTON, Oct. 8, 2025 /PRNewswire/ -- eschbach, developer of Shiftconnector®, an intelligent operations platform for the pharmaceutical industry, has won…

3 months ago